Reducing Skeletal Related Events In Prostate Cancer

Neal D. Shore, MD, FACS, explains the use of the oral agents, abiraterone and enzalutamide, as well as radium-223. He describes the survival benefits found in trials looking at radium-223 and how he now employs it not only after chemotherapy, but also before initiating chemotherapy.

  • Reducing Skeletal-Related Events in Prostate Cancer ( Download)
  • Preventing Skeletal-Related Events in Prostate Cancer ( Download)
  • Identification and Prevention of Skeletal-Related Events ( Download)
  • Optimizing Bone Health in Patients with Prostate Cancer ( Download)
  • Management of Bone Metastases and Bone Health in Patients With Prostate Cancer ( Download)
  • Bone Metastases and Mortality ( Download)
  • Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223 ( Download)
  • Treating Bone Mets with Adam Brufsky, MD, PhD ( Download)
  • Advances in prevention and treatment of bone metastases in prostate cancer ( Download)
  • Putting the Brakes on Prostate Cancer Progression in Bone ( Download)
  • Bone Health in Prostate Cancer ( Download)
  • Assessment of Bone Health and Management of Skeletal-Related Events, Part I ( Download)
  • Bone Metastases and Mortality: Can We Be Doing More ( Download)
  • Asymptomatic Versus Symptomatic Bone Metastases in Prostate Cancer ( Download)
  • Bone-targeted therapies to reduce skeletal morbidity in prostate cancer ( Download)

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com